Michael I Fingerhood, M.D.

Headshot of Michael I Fingerhood
  • Director, Division of Addiction Medicine
  • Professor of Medicine
Male

Expertise

Addiction Medicine, Internal Medicine

Research Interests

Addictions; HIV

Request an Appointment

Insurance Information

Main Phone

Outside of Maryland & Washington D.C.

Request Appointment

International Patients

Request Appointment

Locations

Johns Hopkins Bayview Medical Center

Appointment Phone: 410-550-2999
5200 Eastern Avenue
Mason Lord Building, East Tower, 2nd Floor
Baltimore, MD 21224
Phone: 410-550-2999 | Fax: 410-367-2442
Johns Hopkins Bayview Medical Center - Google Maps

Background

Dr. Michael Fingerhood is a professor of medicine and public health at the Johns Hopkins University. His areas of clinical expertise include addiction medicine and internal medicine.

He earned his M.D. from the Albert Einstein College of Medicine of Yeshiva University. He completed his residency at Johns Hopkins.

Dr. Fingerhood's research interests include substance use disorders, contingency management, hepatitis C and HIV.

He is a member of several professional organizations, including the American Society of Addiction Medicine, the American Academy of HIV Medicine, The Society of General Internal Medicine and the American College of Physicians.

...read more

Titles

  • Director, Division of Addiction Medicine
  • Professor of Medicine

Departments / Divisions

Centers & Institutes

Education

Degrees

  • MD; Albert Einstein College of Medicine (1986)

Residencies

  • Internal Medicine; Johns Hopkins Bayview Medical Center (1990)

Board Certifications

  • American Board of Internal Medicine (Internal Medicine) (1989)
  • American Board of Preventive Medicine (Addiction Medicine) (2018)

Research & Publications

Selected Publications

Press K, Zornberg G, Geller G, Carrese J, Fingerhood M. What patients with addiction disorders need from their primary care physicians: a qualitative study. Substance Abuse 2016; 37:349-55.

Krawczyk N, Feder KA, Fingerhood MI, Saloner B.Racial and ethnic differences in opioid agonist treatment for opioid use disorder in a U.S. national sample. Drug Alcohol Depend 2017Sep 1;178:512-518. doi: 10.1016/j.drugalcdep.2017.06.009.

Krawczyk N, Negron T, Nieto M, Agus D, Fingerhood M. Overcoming medication stigma in peer recovery: a new paradigm.  Substance Abuse. 2018; 39:404-9

Silverman K, Holtyn AF, Rodewald AM, Siliciano RF, Jarvis BP, Subramaniam S, Leoutsakos JM, Getty CA, Ruhs S, Marzinke MA, Fingerhood M. Incentives for viral suppression in people living with HIV: A randomized clinical trial. AIDS Behav. 2019; 23:2337-2346

Hsu YJ, Marsteller JA, Kachur SG, Fingerhood MI. Integration of buprenorphine treatment with primary care: Comparative effectiveness on retention, utilization and cost. Pop Health Managem. 2019; 22:292-9

Contact for Research Inquiries

Phone: 410-550-1134

Activities & Honors

Honors

  • Alpha Omega Alpha
  • Miller-Coulson Academy of Clinical Excellence, Johns Hopkins University School of Medicine, 2009
  • Baltimore City Health Department Equity Leadership Award, Baltimore City Health Department, 2017
  • Physician of the Year, Johns Hopkins Bayview Medical Center, 2018
  • McCarthy Award, Johns Hopkins Bayview Medical Center Board of Trustees, 2018
  • Distinguished Fellow, American Society of Addiction Medicine, 2019
  • Roche Family Foundation Scholar, Johns Hopkins Center for Innovative Medicine, 2020

Memberships

  • American Academy of HIV Medicine
  • American College of Physicians
  • American Society of Addiction Medicine
  • College on Problems of Drug Dependence
  • HIV Medical Association
  • Society of General Internal Medicine

Videos & Media

Recent News Articles and Media Coverage

Opioid-related deaths make a disappointing uptick in early 2020, possibly related to coronavirus, The Baltimore Sun, June 11, 2020

Swearing off alcohol for Dry January? Here are a few helpful tips to get through the month, USA Today, (December 24, 2019)

Overdose patients end up repeatedly in hospital, The Baltimore Sun, Dec. 29, 2014

Programs focus on high-risk patients to reduce spending, USA Today, Sept. 16, 2014

Is this you? Edit Profile
back to top button